Trading Update
14 May 2018
ASX Announcement
Trading Update
Medical Developments International Limited (ASX: MVP) CEO, Mr. John Sharman, warned today that despite the fact that during FY18 Penthrox has been approved for sale in 15 additional countries including Canada, Germany, Mexico, Sweden and numerous other European countries, the upside from this global expansion will not be seen until FY19.
For the full release, please refer to the following link: Trading Update – 14 May 2018